London CO Of Virginia Amgen Inc Transaction History

London CO Of Virginia

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $32,569 - $38,512	-152 Reduced 13.19%	1,000 $222,000
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $1,081 - $1,288	-5 Reduced 0.43%	1,152 $265,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $10,089 - $11,220	-43 Reduced 3.58%	1,157 $294,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $834,164 - $1.02 Million	-4,217 Reduced 77.85%	1,200 $283,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $710,736 - $942,630	3,900 Added 257.09%	5,417 $1.1 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $2,988 - $3,357	-18 Reduced 1.17%	1,517 $280,000
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $3,049 - $3,564	18 Added 1.19%	1,535 $262,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $253,778 - $289,747	1,517	1,517 $283,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

Stay updated on London CO Of Virginia with notifications on news.